Literature DB >> 24969016

Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor.

Dilip K Tosh1, Silvia Paoletta1, Zhoumou Chen2, Steven M Moss1, Zhan-Guo Gao1, Daniela Salvemini2, Kenneth A Jacobson3.   

Abstract

2-Arylethynyl-(N)-methanocarba adenosine 5'-methyluronamides containing rigid N(6)-(trans-2-phenylcyclopropyl) and 2-phenylethynyl groups were synthesized as agonists for probing structural features of the A3 adenosine receptor (AR). Radioligand binding confirmed A3AR selectivity and N(6)-1S,2R stereoselectivity for one diastereomeric pair. The environment of receptor-bound, conformationally constrained N(6) groups was explored by docking to an A3AR homology model, indicating specific hydrophobic interactions with the second extracellular loop able to modulate the affinity profile. 2-Pyridylethynyl derivative 18 was administered orally in mice to reduce chronic neuropathic pain in the chronic constriction injury model. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenylate cyclase; G protein-coupled receptor; Molecular modeling; Purines; Radioligand binding; Structure activity relationship

Mesh:

Substances:

Year:  2014        PMID: 24969016      PMCID: PMC4158450          DOI: 10.1016/j.bmcl.2014.06.006

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

Authors:  Susanna Tchilibon; Bhalchandra V Joshi; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

2.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

3.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

4.  Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands.

Authors:  Susanna Tchilibon; Soo-Kyung Kim; Zhan-Guo Gao; Brian A Harris; Joshua B Blaustein; Ariel S Gross; Heng T Duong; Neli Melman; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2004-05-01       Impact factor: 3.641

5.  125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Authors:  M E Olah; C Gallo-Rodriguez; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

6.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

7.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

Authors:  G J Bennett; Y K Xie
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

Review 8.  Adenosine A2A receptor as a drug discovery target.

Authors:  Manuel de Lera Ruiz; Yeon-Hee Lim; Junying Zheng
Journal:  J Med Chem       Date:  2013-11-15       Impact factor: 7.446

9.  2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.

Authors:  Ombretta Lenzi; Vittoria Colotta; Daniela Catarzi; Flavia Varano; Daniela Poli; Guido Filacchioni; Katia Varani; Fabrizio Vincenzi; Pier Andrea Borea; Silvia Paoletta; Erika Morizzo; Stefano Moro
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

10.  Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Artem Melman; Ben Wang; Bhalchandra V Joshi; Zhan-Guo Gao; Sonia de Castro; Cara L Heller; Soo-Kyung Kim; Lak Shin Jeong; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-08-07       Impact factor: 3.641

View more
  5 in total

1.  Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).

Authors:  Biebele Abel; Dilip K Tosh; Stewart R Durell; Megumi Murakami; Shahrooz Vahedi; Kenneth A Jacobson; Suresh V Ambudkar
Journal:  Mol Pharmacol       Date:  2019-05-24       Impact factor: 4.436

2.  Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists.

Authors:  Dilip K Tosh; Antonella Ciancetta; Eugene Warnick; Steven Crane; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2016-12-09       Impact factor: 7.446

3.  Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2.

Authors:  Biebele Abel; Megumi Murakami; Dilip K Tosh; Jinha Yu; Sabrina Lusvarghi; Ryan G Campbell; Zhan-Guo Gao; Kenneth A Jacobson; Suresh V Ambudkar
Journal:  Eur J Med Chem       Date:  2022-01-10       Impact factor: 6.514

4.  Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists.

Authors:  Dilip K Tosh; Antonella Ciancetta; Philip Mannes; Eugene Warnick; Aaron Janowsky; Amy J Eshleman; Elizabeth Gizewski; Tarsis F Brust; Laura M Bohn; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Omega       Date:  2018-10-04

5.  Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay.

Authors:  Marian Vincenzi; Katarzyna Bednarska; Zbigniew J Leśnikowski
Journal:  Molecules       Date:  2018-07-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.